Consumer Discretionary • Catalog/Specialty Distribution
$3.36 ▲ +0.07
(+2.13%)
MKT CAP: $195.3M • VOL: 211.9K
52W L $2 52W H $4
BZUN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.42B | $1.29B | $1.24B |
| YoY Revenue Growth % | +10.2% | +4.0% | — |
| Gross Profit | $1.05B | $951.9M | — |
| Gross Margin % | 74.1% | 73.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $8.1M | -$15.7M | -$29.1M |
| Operating Margin % | 0.6% | -1.2% | -2.3% |
| Net Income (GAAP) | -$34.6M | -$25.4M | -$39.2M |
| EBITDA (Normalized) | $20.3M | -$1.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $60.1M | $13.9M | $63.1M |
| Capital Expenditures (CapEx) | $15.2M | $18.1M | — |
| Free Cash Flow (FCF) | $44.9M | -$4.2M | $63.1M |
| FCF Margin % | 3.2% | -0.3% | 5.1% |
| Return on Invested Capital (ROIC %) | 1.6% | -3.5% | — |
| Cash & Short-Term Equivalents | $129.7M | $176.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $520.9M | $536.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BZUN.